FBM
Timeline
9 events since 2024Board
Capital
Filings
Establishments
Other
202420252026
2026
Powers of attorney: Frederik Van Remoortel, Ward Overlaet and Anass ArbagePermanent representatives: Kenneth Wills and Bart De Taeye · Board meeting of 23-04-20266 points ▸
- Board meeting, 23-04-2026
- Permanent representative, Kenneth Wills
- Permanent representative, Bart De Taeye
- Power of attorney, Frederik Van Remoortel
- Power of attorney, Ward Overlaet
- Power of attorney, Anass Arbage
Annual accounts 2025 filed PDFabbreviated format · 65 days before the deadline
2025
6 directors appointed, 8 resignationsResignations: Galapagos, Virovet, MoveUp, Montis Biosciences, QbD 'Group, Heran Partners and 2 others · Permanent representatives: Marieke Vermeersch, Erwin Blomsma, Ward Servaes, Gil Beyen, Bart Van Acker, Herman Verrelst and 4 others · Appointments: Allegro, Flen Health, Benno Therapeutics, Gynaia, Ad Hoc Clinical and Tom Aelbrecht (permanent representative) · General meeting of 27-05-202526 points ▸
- General meeting, 27-05-2025
- Director resignation, Galapagos
- Permanent representative, Marieke Vermeersch
- Director resignation, Virovet
- Permanent representative, Erwin Blomsma, mentioned twice in the deed
- Director resignation, MoveUp
- Permanent representative, Ward Servaes
- Director resignation, Montis Biosciences
- Permanent representative, Gil Beyen
- Director resignation, QbD 'Group
- Permanent representative, Bart Van Acker
- Director resignation, Heran Partners
- Permanent representative, Herman Verrelst, mentioned twice in the deed
- Director resignation, BioQube Ventures
- Permanent representative, Dirk Reyn
- Director appointment, Allegro
- Permanent representative, Lucas Decuypere
- Director appointment, Flen Health
- Permanent representative, Philippe Sollie
- Director appointment, Benno Therapeutics
- Director appointment, Gynaia
- Director appointment, Ad Hoc Clinical
- Permanent representative, Nancy Cottigny
- Board meeting, 23-05-2025
- Director resignation, Werner Verbiest (permanent representative)
- Director appointment, Tom Aelbrecht (permanent representative)
Merger: FBM takes over FLANDERS.BIOAppointments: MONTIS BIOSCIENCES BV, APHEA.BIO NV, VIROVET NV, GALAPAGOS NV, VIB VZW, P.M.V. NV and 10 others · Permanent representatives: Gil Hendrik August BEYEN, Isabel Julia René VERCAUTEREN, Erwin BLOMSMA, Marieke Francine VERMEERSCH, Jérôme Laurent Nicole VAN BIERVLIET, Kenneth Maria WILS and 10 others · Resignations: FLANDERS.BIO (director) and MEDVIA (director) · General meeting of 18-02-202537 points ▸
- General meeting, 18-02-2025
- Director appointment, MONTIS BIOSCIENCES BV
- Permanent representative, Gil Hendrik August BEYEN
- Director appointment, APHEA.BIO NV
- Permanent representative, Isabel Julia René VERCAUTEREN
- Director appointment, VIROVET NV
- Permanent representative, Erwin BLOMSMA
- Director appointment, GALAPAGOS NV
- Permanent representative, Marieke Francine VERMEERSCH
- Director appointment, VIB VZW
- Permanent representative, Jérôme Laurent Nicole VAN BIERVLIET
- Director appointment, P.M.V. NV
- Permanent representative, Kenneth Maria WILS
- Director appointment, QBD GROUP NV
- Permanent representative, Bart Jeanne Freddy VAN ACKER
- Director appointment, BIOQUBE VENTURES NV
- Permanent representative, Dirk Maria Jozef REYN
- Director appointment, HIPPOCREATES BV
- Permanent representative, Dirk LOECKX
- Director appointment, SURGI-TEC NV
- Permanent representative, Karina Monique Angèle Anna SCHEERLINCK
- Director appointment, JANSSEN PHARMACEUTICA NV
- Permanent representative, Werner Hendrik Adolf VERBIEST
- Director appointment, KU LEUVEN
- Permanent representative, Christel Alphonsina Gabriella Godelieve VAN GEET
- Director appointment, UNIVERSITAIR ZIEKENHUIS ANTWERPEN (UZA)
- Permanent representative, Guy Henri Joseph HANS
- Director appointment, MOVEUP NV
- Permanent representative, Ward Marie Louis SERVAES
- Director appointment, SCK CEN
- Permanent representative, Koen HASAERS
- Director appointment, Heran Partners BV
- Permanent representative, Herman Karel Gabriel VERRELST
- Director resignation, FLANDERS.BIO
- Director resignation, MEDVIA
- Net-asset statement, 611390.23, 30-11-2024
- Accounting effect, 01-01-2025
- The deed holds 10 more points.
Registered in the Peppol Directory Reachable for e-invoices through 0208:1016786167
Amendment of the articlesGeneral meeting of 06-01-20252 points ▸
- General meeting, 06-01-2025
- Amendment of the articles, article 12
Powers of attorney: Ann Van Gysel and Marc OstBoard meeting of 22-01-20253 points ▸
- Board meeting, 22-01-2025
- Power of attorney, Ann Van Gysel
- Power of attorney, Marc Ost
First establishment Stapelplein 70, Ghent
2024
IncorporationFounders: FLANDERS.BIO VZW and MEDVIA VZW · Appointments: FLANDERS.BIO VZW (director) and MEDVIA VZW (director) · Permanent representatives: Dirk Reyn and Herman Verrelst · published on 10-12-20247 points ▸
- Founder, FLANDERS.BIO VZW
- Founder, MEDVIA VZW
- Registered office clause, Sint-Michielsstraat 18, 9000 Gent
- Director appointment, FLANDERS.BIO VZW
- Permanent representative, Dirk Reyn
- Director appointment, MEDVIA VZW
- Permanent representative, Herman Verrelst
- The deed holds 1 more point.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
FBM was incorporated on 29 November 2024 as a non-profit association by FLANDERS.BIO VZW and MEDVIA VZW.12 In 2025 the company absorbed FLANDERS.BIO and MEDVIA by merger.34 The board currently has 25 members.5